Amphastar Pharmaceuticals Inc (AMPH)
Total Costs & Expenses
$615.73M
TTM · Period ending: · USD
AMPH Total Costs & Expenses
Latest reported$615.73Mperiod ending
Latest reported$615.73Mperiod ending
AMPH TTM Total Costs & Expenses ($212.07M → $615.73M)
TTM Total Costs & Expenses
High-resolution chart · PNG
AMPH total costs & expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| 615,734,000 | |
| 603,790,000 | |
| 579,484,000 | |
| 573,364,000 | |
| 538,615,000 | |
| 533,562,000 | |
| 524,153,000 | |
| 506,899,000 | |
| 483,006,000 | |
| 464,645,000 | |
| 447,408,000 | |
| 420,474,000 | |
| 409,497,000 | |
| 399,325,000 | |
| 391,490,000 | |
| 390,934,000 | |
| 381,462,000 | |
| 373,921,000 | |
| 367,881,000 | |
| 364,288,000 | |
| 356,773,000 | |
| 354,398,000 | |
| 338,892,000 | |
| 329,477,000 | |
| 327,296,000 | |
| 316,642,000 | |
| 322,396,000 | |
| 326,914,000 | |
| 322,174,000 | |
| 317,997,000 | |
| 303,346,000 | |
| 277,267,000 | |
| 265,010,000 | |
| 254,115,000 | |
| 243,713,000 | |
| 249,700,000 | |
| 247,390,000 | |
| 241,977,000 | |
| 239,142,000 | |
| 233,502,000 | |
| 242,688,000 | |
| 249,138,000 | |
| 258,211,000 | |
| 258,620,000 | |
| 258,523,000 | |
| 244,475,000 | |
| 228,003,000 | |
| 217,007,000 | |
| 208,578,000 | |
| 209,129,000 | |
| 212,065,000 | |
| 206,369,000 |